Evidence map›Paper›PMID 34198546›Full record

ReviewInternational journal of molecular sciences2021

The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.

Gillian A Kelly-Robinson, James A Reihill, Fionnuala T Lundy, Lorcan P McGarvey, John C Lockhart, Gary J Litherland, Keith D Thornbury, S Lorraine Martin

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. An endogenous human peptide derived from αNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  10. Heterozygous pathogenic variants inOpen life sciences · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Mendelian causes of early-onset emphysema: a review of the current literature.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Gillian A Kelly-RobinsonSchool of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland BT9 7BL, UK.
James A ReihillSchool of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland BT9 7BL, UK.ORCID 0000-0001-8599-5198
Fionnuala T LundyWellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland BT9 7BL, UK.ORCID 0000-0003-3150-1150
Lorcan P McGarveyWellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland BT9 7BL, UK.
John C LockhartInstitute for Biomedical and Environmental Health Research, School of Health and Life Sciences, University of the West of Scotland, Paisley, Scotland PA1 2BE, UK.ORCID 0000-0001-8115-9205
Gary J LitherlandInstitute for Biomedical and Environmental Health Research, School of Health and Life Sciences, University of the West of Scotland, Paisley, Scotland PA1 2BE, UK.
Keith D ThornburySmooth Muscle Research Centre, Dundalk Institute of Technology, A91 HRK2 Dundalk, Ireland.
S Lorraine MartinSchool of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland BT9 7BL, UK.ORCID 0000-0002-1923-0610
Queen's University Belfast · GBUniversity of the West of Scotland · GBDundalk Institute of Technology · IE

Funding

This study was supported by the Borders and Regions Airways Training Hub project (BREATH; INT-VA/045) funded by the European Union (EU), under the INTERREG VA Programme, managed by the Special EU Programmes Body INT-VA/045
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a debilitating heterogeneous disease characterised by unregulated proteolytic destruction of lung tissue mediated via a protease-antiprotease imbalance. In COPD, the relationship between the neutrophil serine protease, neutrophil elastase, and its endogenous inhibitor, alpha-1-antitrypsin (AAT) is the best characterised. AAT belongs to a superfamily of serine protease inhibitors known as serpins. Advances in screening technologies have, however, resulted in many members of the serpin superfamily being identified as having differential expression across a multitude of chronic lung diseases compared to healthy individuals. Serpins exhibit a unique suicide-substrate mechanism of inhibition during which they undergo a dramatic conformational change to a more stable form. A limitation is that this also renders them susceptible to disease-causing mutations. Identification of the extent of their physiological/pathological role in the airways would allow further expansion of knowledge regarding the complexity of protease regulation in the lung and may provide wider opportunity for their use as therapeutics to aid the management of COPD and other chronic airways diseases.

Indexed as

AnimalsDisease Models, AnimalHumansPulmonary Disease, Chronic ObstructiveSerine ProteasesSerpinsSerine ProteasesSerpinsantiproteasechronic obstructive pulmonary disease (COPD)protease inhibitorserine proteaseserpin

Identifiers

PMID34198546
PMCPMC8231800
OpenAlexW3170465101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.